Amberstone Biosciences, Inc. is an early-stage biotechnology company focused on developing next-generation T cell engagers (TCEs) for the treatment of solid tumors. The company's proprietary T-MATE platform leverages the acidic environment found in tumor microenvironment to locally activate TCEs, thereby minimizing on-target toxicity and enabling the development of safer and more effective therapeutics. Amberstone is advancing a diverse pipeline of T-MATE-based therapeutics for solid tumors that are intractable with conventional TCEs. The company is headquartered in Irvine, California.
Company Details
- Employees
- 15
- Founded
- 2018
- Address
- 15300 Barranca Pkwy,
- Phone
- 9492697918
- co****@****bio.com
- Industry
- Biotechnology
- Website
- https://www.amberstonebio.com
- HQ
- Irvine, California
Amberstone Biosciences Questions
Amberstone Biosciences's helpline number is 9492697918
Amberstone Biosciences's website is https://www.amberstonebio.com
Amberstone Biosciences's LinkedIn profile is https://www.linkedin.com/company/amberstone-biosciences
Amberstone Biosciences has
15 employees.
View email and phone details for 15
employees at Amberstone Biosciences.
Amberstone Biosciences's industry is
Biotechnology
Amberstone Biosciences's top competitors are
Aracari Biosciences Inc.,
Genetex, Inc.,
Immunis, Inc.,
Advanbio,
Aivita Biomedical, Inc.,
Aureka Biotechnologies, Inc.,
Invitrx Therapeutics,
Arvetas Biosciences,
Nexgen Pharma,
Translucence Biosystems.
Amberstone Biosciences's support email address is contact@amberstonebio.com
Amberstone Biosciences's categories are Biotechnology
Amberstone Biosciences's founding year is 2018
